CURAXIS PHARMACEUTICAL CORP EBITDA
CURAXIS PHARMACEUTICAL CORP EBITDA
- 2012-03-31: Basis Reported; EBITDA (m); Operating income -$345.00K; Depreciation and amortization (m).
- 2011-09-30: Basis Reported; EBITDA (m); Operating income -$360.00K; Depreciation and amortization (m).
- 2011-06-30: Basis Reported; EBITDA (m); Operating income -$470.00K; Depreciation and amortization (m).
- 2011-03-31: Basis Reported; EBITDA (m); Operating income -$630.00K; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2012-03-31 | Reported | (m) | -$345.00K | (m) | (m) | (m) | $0.00 | -$100.00K | (m) | $19.00K | (m) | (m) |
|---|
| 2011-09-30 | Reported | (m) | -$360.00K | (m) | (m) | (m) | (m) | (m) | (m) | $14.00K | (m) | (m) |
|---|
| 2011-06-30 | Reported | (m) | -$470.00K | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) |
|---|
| 2011-03-31 | Reported | (m) | -$630.00K | (m) | (m) | (m) | $0.00 | -$499.00K | (m) | $2.00K | (m) | (m) |
|---|
| 2010-09-30 | Reported | (m) | -$588.00K | (m) | (m) | (m) | (m) | (m) | (m) | $19.00K | (m) | (m) |
|---|
| 2010-06-30 | Reported | (m) | -$435.00K | (m) | (m) | (m) | (m) | (m) | (m) | $23.00K | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2011-12-31 | Reported | (m) | -$1.92M | (m) | (m) | (m) | (m) | -$857.00K | (m) | $33.00K | (m) | (m) |
|---|
| 2010-12-31 | Reported | (m) | -$1.94M | (m) | (m) | (m) | $2.00K | -$1.32M | (m) | $78.00K | (m) | (m) |
|---|